The beneficial effect of beta2-blockers on humoral autoimmune disorders.
Namazi
Mohammed R
MR
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000917:Antibody Formation; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D018343:Receptors, Adrenergic, beta-2 / Q000378:metabolism*
D000319:Adrenergic beta-Antagonists; D018343:Receptors, Adrenergic, beta-2